Physician profile
Noel C Boyd
NPI 1568465615
$37,061.51
in general payments reported to CMS, 2019-2025
35 companies · $392 in 2025
The $392 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $317 · 2021: $18K · 2022: $17K · 2023: $518 · 2024: $556 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,453 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,453.35 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $33,200.00 | 2021-2022 | |
| Renovia INC | $811.21 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $437.29 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $373.89 | 2019-2023 | Lo Loestrin Fe |
| Myovant Sciences INC. | $287.82 | 2021-2022 | |
| Mayne Pharma Commercial LLC | $236.28 | 2021-2024 | |
| Pfizer INC. | $167.43 | 2019-2024 | |
| Millicent US INC | $148.84 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Astellas Pharma US INC | $129.50 | 2021-2025 | Veozah, Myrbetriq |
| Welch Allyn | $114.22 | 2021 | |
| Organon LLC | $106.62 | 2021-2024 | Nexplanon |
| Biogen, INC. | $102.68 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $97.90 | 2021-2024 | Phexxi |
| Coopersurgical, INC. | $92.19 | 2020-2025 | Paragard T 380a, Sos, Wallach Cryosurgical Equipment |
| Bayer Healthcare Pharmaceuticals INC. | $83.78 | 2019-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $76.00 | 2023-2025 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $73.89 | 2019-2024 | Ova1 |
| Avion Pharmaceuticals | $69.86 | 2019-2020 | |
| Shield Therapeutics INC | $56.42 | 2023-2024 | Accrufer |
| Amag Pharmaceuticals, INC. | $52.50 | 2019 | |
| Allergan, INC. | $44.02 | 2019 | |
| Ethicon US, LLC | $42.40 | 2022 | |
| Scynexis, INC. | $34.12 | 2021-2022 | |
| Urovant Sciences INC | $33.94 | 2022 | |
| Kci USA, INC. | $29.28 | 2020 | |
| Meditrina | $26.66 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $21.44 | 2021 | |
| Optumhealth Care Solutions, LLC | $19.77 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Vertical Pharmaceuticals, LLC | $19.05 | 2019 | |
| Acessa Health INC. | $18.58 | 2019 | |
| Currax Pharmaceuticals LLC | $14.43 | 2023 | Contrave |
| Minerva Surgical, INC | $14.14 | 2023 | |
| Gilead Sciences, INC. | $13.79 | 2019 | |
| Hologic Sales and Service, LLC | $11.57 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Noel Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.